uce
ProgressImage ProgressImage
Neuland Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code 524558 border-img ISIN Demat INE794A01010 border-img Book Value 1,081.52 border-img NSE Symbol NEULANDLAB border-img Div & Yield % 0.11 border-img Market Cap ( Cr.) 15818.55 border-img P/E 66.08 border-img EPS 186.59 border-img Face Value 10
Quarters
ParticularsDec 2024
()
Sep 2024
()
Jun 2024
()
Gross Sales398.03310.84439.60
Other Operating Income0.000.000.00
Other Income 59.684.3325.43
Total Income457.72315.18465.03
Total Expenditure 311.66249.50315.78
PBIDT146.0665.67149.26
Interest 2.221.062.67
PBDT143.8464.61146.59
Depreciation16.3016.0716.28
Tax24.9212.2130.58
Fringe Benefit Tax0.000.000.00
Deferred Tax1.234.371.39
Reported Profit After Tax101.3931.9698.34
Extra-ordinary Items 44.340.0015.57
Adjusted Profit After Extra-ordinary item57.0531.9682.77
    
EPS (Unit Curr.)79.0324.9176.65
EPS (Adj) (Unit Curr.)79.0324.9176.65
Calculated EPS (Unit Curr.)78.6024.7776.23
Calculated EPS (Adj) (Unit Curr.)78.6024.7776.23
Calculated EPS (Ann.) (Unit Curr.)314.3999.09304.92
Calculated EPS (Adj) (Ann.) (Unit Curr.)314.3999.09304.92
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity12.9012.9012.90
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)36.7021.1333.95
PBDTM(%)36.1420.7933.35
PATM(%)25.4710.2822.37
x
x
×
Let's Chat
close
refresh